Jessica Karen Wong, MD, MEng

Dr. Jessica Wong
This physician is not currently rated. Why?

Why is this doctor not rated?


To ensure the accuracy of our patient satisfaction scores, we require that providers who see patients receive a minimum number of completed patient-submitted surveys before their reviews are listed on their profiles. Star ratings on this site are collected on a rolling basis from the previous 12 months.
Additionally, some of the physicians listed on our site do not see patients directly, and therefore, do not receive evaluation and ratings from patients.

More about patient ratings
Request an Appointment

Clinical Locations

Assistant Professor, Department of Radiation Oncology
Assistant Director, Radiation Oncology Residency and Fellowship Training Program

Treatment Focus

Stereotactic Body Radiation Therapy (SBRT), Intensity Modulated Radiation Therapy (IMRT), Hypofractionated Radiation Therapy, High Dose Rate Prostate Brachytherapy, Anal Cancer

Key Awards

RSNA Roentgen Resident/Fellow Research Award 2019

Treatment Philosophy

I chose to join the Radiation Oncology faculty at Fox Chase after completing my training here because I believe that cancer is best treated in a multidisciplinary setting with the highest standard of clinical care. Here, cancer patients receive outstanding, compassionate treatment delivered with state of the art technology. I strive to maintain strong relationships with my patients and work with them to develop personalized treatment plans for their individual needs. I particularly enjoy our multi-disciplinary approach, as I feel that much more can be accomplished when people of different backgrounds and expertise work together on a common goal.

My primary treatment site is genitourinary malignancies, where I treat patients with both external beam radiation and brachytherapy. I am particularly interested in Prostate High Dose Rate (HDR) Brachytherapy which can reduce toxicity for certain patients while maintaining excellent cancer control. Prostate cancer has also been the focus of my academic interests and I have multiple active clinical and translational studies, including a national study comparing moderately-hypofractionated intensity modulated radiation therapy (IMRT) and proton radiation therapy.

After earning my Bachelor of Science in Chemical-Biological Engineering at the Massachusetts Institute of Technology and a Master’s of Engineering in Biomedical Engineering through the Harvard-MIT Division of Health Science and Technology, I attended medical school at the University of Tennessee. I believe the combination of my science and engineering background with my clinical training gives me a unique perspective to pursue clinical and translational research. Having a strong science background allows me to determine what scientific investigations are feasible and having a strong clinical background allows me to ensure that experiments are clinically relevant, allowing for the most immediate impact on patient care. I seek to further the understanding of radiation’s interaction with the body to improve treatment techniques and develop novel cancer treatments.

In addition to quality patient care and cutting-edge research, I also enjoy radiation oncology education and mentorship. I am active in the American Society for Radiation Oncology (ASTRO), Society of Women in Radiation Oncology (SWRO), American Brachytherapy Society (ABS), Association for Directors of Radiation Oncology Programs (ADROP), and Radiation Oncology Education Collaborative Study Group (ROECSG). I am proud to serve as the Assistant Director of our radiation oncology residency program and fellowship training program as our talented medical students, residents, and fellows are the future of our field.

Educational Background

  • Chief Resident, Fox Chase Cancer Center, Philadelphia, PA, 2018-2019
  • Resident, Radiation Oncology, Fox Chase Cancer Center, Philadelphia, PA, 2016–2020
  • Resident, Preliminary Medicine, University of Tennessee, Memphis, TN, 2016
  • MD, University of Tennessee College of Medicine, Memphis, TN, 2015
  • MEng Biomedical Engineering, Harvard-MIT Division of Health Sciences and Technology, Cambridge, MA, 2011
  • BS, Chemical-Biological Engineering, Massachusetts Institute of Technology, Cambridge, MA, 2010


  • American Society for Radiation Oncology (ASTRO)
  • American Brachytherapy Society (ABS)
  • Association for Directors of Radiation Oncology Programs (ADROP)
  • Radiation Oncology Education Collaborative Study Group (ROECSG)
  • Society of Women in Radiation Oncology (SWRO)

Honors & Awards

  • RSNA Roentgen Resident/Fellow Research Award 2019

Bob Sokolove

  • Prostate Cancer

I’m 68 years old and a very active person. When I’m not busy working as a lawyer for a firm in Bucks County, which is just north of Philadelphia, you can find me riding my bike, playing and watching sports, or traveling with my wife, Caroline. I’ve never been the wait-and-see type.


Research Interests

Prostate Cancer, High Dose Rate Brachytherapy, Translational Research, Radio-Immunotherapy

Selected Publications

Avkshtol V, Ruth KJ, Ross EA, Hallman MA, Greenberg RE, Price RA Jr, Leachman B, Uzzo RG, Ma C, Chen D, Geynisman DM, Sobczak ML, Zhang E, Wong JK, Pollack A, Horwitz EM. Ten-Year Update of a Randomized, Prospective Trial of Conventional Fractionated Versus Moderate Hypofractionated Radiation Therapy for Localized Prostate Cancer. J Clin Oncol. 2020 May 20;38(15):1676-1684. PMID: 32119599

Wong JK, Handorf E, Lee D, Jain R, Zhang E, Cooper HS, Farma JM, Dotan E, Meyer JE. Toxicity and outcomes in older versus younger patients treated with trimodality therapy for locally advanced rectal cancer. J Geriatr Oncol. 2020 May 4; PMID: 32381438.

Wong JK, Shaikh T, DeMora L, Zhang E, Borghaei H, Hayes SB, Kumar S, Meyer JE, Hallman MA. Predictors of Distant Recurrence Following Stereotactic Body Radiation Therapy for Stage I Non-Small Cell Lung Cancer. Am J Clin Oncol. 2020 Apr;43(4):243-248.  PMID: 31913907

Pai Panandiker AS, Wong JK, Nedelka MA, Wu S, Gajjar A, Broniscer A. (2014), Effect of time from diagnosis to start of radiotherapy on children with diffuse intrinsic pontine glioma. Pediatr Blood Cancer. 2014, 61 (1180-1183). PMID: 24482196

Additional Publications

The following ratings and reviews are based on verified feedback collected from independently administered patient experience surveys. The ratings and comments submitted by patients reflect their own views and opinions. Patient identities are withheld to ensure confidentiality and privacy. Learn more about our Patient Experience Ratings.

Ratings Breakdown

Loading ...

Patient comments

Loading ...